Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 62101-62150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06304233
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease
N/AActive, not recruiting
120 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2038
3 conditions2 sponsors2 locations
NCT06123884
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
PHASE2/PHASE3Recruiting
526 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06183021
The Effect of Cryotherapy on the Outcome of Pulpotomy and Root Canal Treatment
NARecruiting
144 participants
Started: Dec 13, 2023 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT06127446
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
N/ARecruiting
300 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2031
1 condition9 sponsors8 locations
NCT06088030
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
PHASE2Recruiting
50 participants
Started: Dec 13, 2023 · Completed: Dec 14, 2031
3 conditions2 sponsors1 location
NCT06101342
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
PHASE2Active, not recruiting
181 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2028
1 condition4 sponsors9 locations
NCT04907136
Developing and Testing Health Warning Labels on the ENDS Device
NARecruiting
210 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06575881
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
N/ARecruiting
200 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2029
3 conditions1 sponsor1 location
NCT06074497
This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy with Envafolimab in Patients with Advanced or Metastatic Solid Tumors.
PHASE1Active, not recruiting
54 participants
Started: Dec 13, 2023 · Completed: May 30, 2026
1 condition1 sponsor3 locations
NCT05837104
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
PHASE2Recruiting
40 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06185192
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
NARecruiting
100 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
PHASE3Recruiting
765 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2028
1 condition2 sponsors132 locations
NCT04322734
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
N/ARecruiting
500 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2028
6 conditions2 sponsors2 locations
NCT06274710
ODYSSEE Kidney Health Trial
NARecruiting
344 participants
Started: Dec 13, 2023 · Completed: Apr 13, 2026
1 condition4 sponsors1 location
NCT06315296
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
NARecruiting
60 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2028
5 conditions1 sponsor1 location
NCT06003348
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
PHASE4Recruiting
25 participants
Started: Dec 13, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06127030
Brief Behavioral Teacher Training for Behavioral Difficulties
NAActive, not recruiting
60 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05951959
A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
PHASE2Active, not recruiting
108 participants
Started: Dec 13, 2023 · Completed: Jul 7, 2028
1 condition1 sponsor29 locations
NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
PHASE3Recruiting
1,200 participants
Started: Dec 13, 2023 · Completed: Sep 7, 2032
2 conditions1 sponsor189 locations
NCT05734105
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
PHASE3Recruiting
54 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor70 locations
NCT06647459
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
N/ARecruiting
200 participants
Started: Dec 13, 2023 · Completed: Jan 1, 2027
2 conditions1 sponsor1 location
NCT06263075
Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
N/ARecruiting
30 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05603273
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
NARecruiting
40 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT07037888
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
PHASE4Recruiting
100 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06830070
Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy
N/AActive, not recruiting
70 participants
Started: Dec 13, 2023 · Completed: May 31, 2025
3 conditions1 sponsor1 location
NCT06179446
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
PHASE1Active, not recruiting
157 participants
Started: Dec 13, 2023 · Completed: Sep 25, 2025
3 conditions1 sponsor4 locations
NCT06064591
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
N/ARecruiting
430 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
3 conditions6 sponsors3 locations
NCT04924270
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
PHASE2Recruiting
200 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
6 conditions3 sponsors1 location
NCT06168266
Effects of Eccentric Exercise Training in Patients With COPD
NARecruiting
170 participants
Started: Dec 13, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06011109
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PHASE1/PHASE2Recruiting
30 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2026
2 conditions1 sponsor2 locations
NCT06058793
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
PHASE3Active, not recruiting
138 participants
Started: Dec 13, 2023 · Completed: Oct 7, 2025
1 condition1 sponsor56 locations
NCT06021925
Obstetrical History and Anti-HLA Antibodies Level
N/ARecruiting
6,000 participants
Started: Dec 13, 2023 · Completed: Jun 13, 2024
2 conditions2 sponsors1 location
NCT06105931
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
PHASE1Recruiting
15 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2028
2 conditions2 sponsors1 location
NCT06141473
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
PHASE3Recruiting
1,600 participants
Started: Dec 13, 2023 · Completed: May 6, 2027
1 condition1 sponsor358 locations
NCT06184100
Virtual Self-Management Program for JIA
NARecruiting
100 participants
Started: Dec 13, 2023 · Completed: Mar 31, 2026
1 condition6 sponsors1 location
NCT07049289
Telemonitoring in Arterial Hypertension
NAActive, not recruiting
60 participants
Started: Dec 13, 2023 · Completed: Sep 9, 2025
2 conditions1 sponsor1 location
NCT05894122
Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)
N/ARecruiting
40 participants
Started: Dec 13, 2023 · Completed: Dec 12, 2025
2 conditions1 sponsor1 location
NCT06149000
Migraine Headache Mitigation Utilizing Avulux
NANot yet recruiting
40 participants
Started: Dec 13, 2023 · Completed: Jun 20, 2024
3 conditions1 sponsor0 locations
NCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
PHASE2Recruiting
190 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor51 locations
NCT05839392
Novel Approaches to Target MECOM/EVI1 in AML
NARecruiting
24 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05761223
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
PHASE1/PHASE2Recruiting
151 participants
Started: Dec 13, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors5 locations
NCT06083870
An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC
PHASE1Recruiting
35 participants
Started: Dec 13, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06170671
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
N/AActive, not recruiting
250 participants
Started: Dec 13, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor19 locations
NCT05174884
Casea S Contraceptive Implants (Casea S) Trial
PHASE1Active, not recruiting
20 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06164925
Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application
N/ARecruiting
300 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT06203899
Depression and Suicide Prevention in Adolescents Attending Special Schools
NARecruiting
236 participants
Started: Dec 13, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT06282588
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
PHASE2/PHASE3Recruiting
493 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2030
1 condition3 sponsors11 locations
NCT06091865
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
PHASE3Active, not recruiting
904 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2029
1 condition1 sponsor149 locations
NCT04997993
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
PHASE1Recruiting
24 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06092554
Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)
NARecruiting
186 participants
Started: Dec 13, 2023 · Completed: Jul 15, 2026
1 condition2 sponsors9 locations